Robert Bresalier, MD

Peer-Reviewed Articles

1. Wei, D, Lin, X, Bresalier, R. Reframing cancer cachexia. Signal Transduction and Targeted Therapy 10(1), 2025. e-Pub 2025. PMID: 41219223.
2. Wei, D, Lin, X, Bresalier, R. Reframing cancer cachexia. Signal Transduction and Targeted Therapy 10(1):370, 2025. e-Pub 2025.
3. Bresalier, R, Young, G, Senore, C. Evaluating New Non-invasive Screening Tests for Colorectal Cancer. Digestive diseases and sciences 70(5):1591-1594, 2025. e-Pub 2025. PMID: 40119244.
4. Bresalier, R, Shaheen, NJ, Hernandez, M, Buttar, NS, Marcon, N, Wani, S, Muthusamy, R, Falk, GW, Johnson, TT, Yan, P, Huo, X, Castille, TA, Della’Zanna, G, Richmond, E, Jack Lee, J, Brown, PH, Souza, RF. Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication with Radiofrequency Ablation. Digestive diseases and sciences 70(3):1034-1042, 2025. e-Pub 2025. PMID: 39934623.
5. Crockett, SD, Shaukat, A, Delau, O, Stoffel, EM, Church, T, Syngal, S, Bresalier, R. Risk Factors for Serrated Polyps. American Journal of Gastroenterology 119(12):2532-2539, 2024. e-Pub 2024. PMID: 39382983.
6. Bresalier, R. Next-Generation Screening for Colorectal Cancer, an Incremental Approach to a Global Disease. Cancer Prevention Research 17(3):93-96, 2024. e-Pub 2024. PMID: 38437584.
7. Wei D, Wang L, Zuo X, Maitra A, Bresalier RS. A small molecule with big impact: MRTX1133 targets the KRASG12D mutation in pancreatic cancer. Clin Cancer Res 30(4):655-662, 2024. e-Pub 2023. PMID: 37831007.
8. Bresalier RS, Senore C, Young GP, Allison J, Benamouzig R, Benton S, Bossuyt PMM, Caro L, Carvalho B, Chiu HM, Coupé VMH, de Klaver W, de Klerk CM, Dekker E, Dolwani S, Fraser CG, Grady W, Guittet L, Gupta S, Halloran SP, Haug U, Hoff G, Itzkowitz S, Kortlever T, Koulaouzidis A, Ladabaum U, Lauby-Secretan B, Leja M, Levin B, Levin TR, Macrae F, Meijer GA, Melson J, O'Morain C, Parry S, Rabeneck L, Ransohoff DF, Sáenz R, Saito H, Sanduleanu-Dascalescu S, Schoen RE, Selby K, Singh H, Steele RJC, Sung JJY, Symonds EL, Winawer SJ, Working Group MOTWECCSNTEE. An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut 72(10):1904-1918, 2023. e-Pub 2023. PMID: 37463757.
9. Wei D, Wang L, Liu Y, Hafley MA, Tan L, Lorenzi PL, Yang P, Zuo X, Bresalier RS. Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression. Dig Dis Sci 68(7):3043-3058, 2023. e-Pub 2023. PMID: 37071246.
10. Grizzi F, Chiriva-Internati M, Miranda E, Zaharie R, Hajjar NA, Zaharie F, Del Arco CD, Fernández-Aceñero MJ, Bresalier RS, Mois E. Sperm protein antigen 17 and Sperm flagellar 1 cancer testis antigens are expressed in a rare case of ciliated foregut cyst of the common hepatic duct. Pathol Res Pract 247:154546, 2023. e-Pub 2023. PMID: 37224658.
11. Tian Y, Denda-Nagai K, Tsukui T, Ishii-Schrade KB, Okada K, Nishizono Y, Matsuzaki K, Hafley M, Bresalier RS, Irimura T. Mucin 21 confers resistance to apoptosis in an O-glycosylation-dependent manner. Cell Death Discov 8(1):194, 2022. e-Pub 2022. PMID: 35410995.
12. Li H, Vanarsa K, Zhang T, Soomro S, Cicalese PA, Duran V, Dasari S, Lee KH, Pedroza C, Kisiel JB, Qin H, Bresalier RS, Chia N, Mohan C. Comprehensive aptamer-based screen of 1317 proteins uncovers improved stool protein markers of colorectal cancer. J Gastroenterol 56(7):659-672, 2021. e-Pub 2021. PMID: 34117903.
13. Bresalier RS, Grady WM, Markowitz SD, Nielsen HJ, Batra SK, Lampe PD. Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation. Cancer Epidemiol Biomarkers Prev 29(12):2431-2440, 2020. e-Pub 2020. PMID: 32299850.
14. Grizzi F, Qehajaj D, Yiu D, Bresalier RS, Chiriva-Internati M. PD-L1, fibrosis, and immunotherapy in hepatocellular carcinoma: the importance of a scientific method to explore observations and answer questions. Surg Today 50(10):1318-1319, 2020. e-Pub 2020. PMID: 32002663.
15. Lech Pedersen N, Mertz Petersen M, Ladd JJ, Lampe PD, Bresalier RS, Davis GJ, Demuth C, SØ J, Andersen CL, Ferm L, Christensen IJ, Nielsen HJ. Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures. Clin Chim Acta 507:39-53, 2020. e-Pub 2020. PMID: 32272156.
16. Bresalier RS, Chapkin RS. Human Microbiome in Health and Disease: The Good, the Bad, and the Bugly. Dig Dis Sci 65(3):671-673, 2020. e-Pub 2020. PMID: 32076932.
17. Abu-Sbeih H, Ali FS, Tang T, Coronel E, Lee HJ, Pande M, Bresalier RS, Raju GS, Wang Y. Rate of colorectal neoplasia in patients with Hodgkin lymphoma. Colorectal Dis 22(2):154-160, 2020. e-Pub 2020. PMID: 31541529.
18. Abu-Sbeih H, Ali FS, Qiao W, Lum P, Shafi MA, Bresalier RS, Hawk E, Raju GS, Wang Y. Patients with non-colorectal cancers may be at elevated risk of colorectal neoplasia. J Cancer 11(11):3192-3198, 2020. e-Pub 2020. PMID: 32231724.
19. Bresalier RS, Souza RF. A Goblet (Cell) Half Full: What Do We Really Know About Barrett's Esophagus-A Tribute to Emmet Keeffe. Dig Dis Sci 63(8):1985-1987, 2018. e-Pub 2018. PMID: 29948560.
20. Passarelli MN, Barry EL, Zhang D, Gangar P, Rees JR, Bresalier RS, McKeown-Eyssen G, Karagas MR, Baron JA. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas. Br J Dermatol 179(2):337-344, 2018. e-Pub 2018. PMID: 29570772.
21. Huo X, Zhang X, Yu C, Cheng E, Zhang Q, Dunbar KB, Pham TH, Lynch JP, Wang DH, Bresalier RS, Spechler SJ, Souza RF. Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus. Gut 67(4):606-615, 2018. e-Pub 2018. PMID: 28442495.
22. Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, Jin J, Liu B, Xie M, Sudo K, Shiozaki H, Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song S. Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors. Br J Cancer 118(1):52-61, 2018. e-Pub 2018. PMID: 29136404.
23. Zhao W, Ajani JA, Sushovan G, Ochi N, Hwang R, Hafley M, Johnson RL, Bresalier RS, Logsdon CD, Zhang Z, Song S. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling. Gastroenterology. e-Pub 2017. PMID: 29274868.
24. Mirandola L, Pedretti E, Figueroa JA, Chiaramonte R, Colombo M, Chapman C, Grizzi F, Patrinicola F, Kast WM, Nguyen DD, Rahman RL, Daver N, Ruvolo P, Post SM, Bresalier RS, Chiriva-Internati M. Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy. Oncotarget 8(43):74378-74390, 2017. e-Pub 2017. PMID: 29088794.
25. Fedirko V, McKeown-Eyssen G, Serhan CN, Barry EL, Sandler RS, Figueiredo JC, Ahnen DJ, Bresalier RS, Robertson DJ, Anderson CW, Baron JA. Plasma lipoxin A4and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas. Mol Carcinog 56(8):1977-1983, 2017. e-Pub 2017. PMID: 28218420.
26. Anderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome. Gastroenterology 152(8):1933-1943.e5, 2017. e-Pub 2017. PMID: 28219690.
27. Barry EL, Peacock JL, Rees JR, Bostick RM, Robertson DJ, Bresalier RS, Baron JA. Vitamin D receptor genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol 3(5):628-635, 2017. e-Pub 2017. PMID: 27978548.
28. Poneros JM, Faye AS, Barr Fritcher EG, Sen A, Anandasabapathy S, Bresalier RS, Marcon N, Turgeon DK, Appelman H, Normolle D, Morrison LE, Brenner DE, Halling KC. A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett's Esophagus. Dig Dis Sci 62(5):1216-1222, 2017. e-Pub 2017. PMID: 28265829.
29. Rees JR, Mott LA, Barry EL, Baron JA, Bostick RM, Figueiredo JC, Bresalier RS, Robertson DJ, Peacock JL. Lifestyle and Other Factors Explain One-Half of the Variability in the Serum 25-Hydroxyvitamin D Response to Cholecalciferol Supplementation in Healthy Adults. J Nutr 146(11):2312-2324, 2016. e-Pub 2016. PMID: 27683872.
30. Pohl H, Robertson DJ, Mott LA, Ahnen DJ, Burke CA, Barry EL, Bresalier RS, Figueiredo JC, Shaukat A, Sandler RS, Baron JA. Association between adenoma location and risk of recurrence. Gastrointest Endosc 84(4):709-16, 2016. e-Pub 2016. PMID: 26975233.
31. Ilmer M, Mazurek N, Gilcrease MZ, Byrd JC, Woodward WA, Buchholz TA, Acklin K, Ramirez K, Hafley M, Alt E, Vykoukal J, Bresalier RS. Low expression of galectin-3 is associated with poor survival in node-positive breast cancer and mesenchymal phenotype in breast cancer stem cells. Breast Cancer Res 18(18):97-109, 2016. e-Pub 2016. PMID: 27687248.
32. Ilmer M, Mazurek N, Byrd JC, Ramirez K, Hafley M, Alt E, Vykoukal J, Bresalier RS. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor initiating cancer cells with heightened stem cell characteristics. Cell Death Dis 7(8):e2337, 2016. e-Pub 2016. PMID: 27512958.
33. Rees JR, Mott LA, Barry EL, Baron JA, Figueiredo JC, Robertson DJ, Bresalier RS, Peacock JL. Randomized controlled trials: who fails run-in?. Trials 17:374, 2016. e-Pub 2016. PMID: 27474021.
34. Raju G, Lum P, Ross W, Thirumurthi S, Miller E, Lynch P, Lee J, Bhutani M, Shafi M, Weston B, Pande M, Bresalier R, Rashid A, Mishra L, Davila M, Stroehlein J. Outcome of Endoscopic Mucosal Resection As an Alternative to Surgery in Patients with Complex Colon Polyps. Gastrointest Endosc. e-Pub 2016. PMID: 26859866.
35. Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hibshoosh H, Cheung K, Friedman RA, Yang CS, Milne GL, Liu DD, Lee JJ, Abdul K, Bigg M, Foreman J, Su T, Wang X, Ahmed A, Neugut AI, Akpa E, Lippman SM, Perloff M, Brown PH, Lightdale CJ. Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus. Cancer Prev Res (Phila) 8(12):1131-7, 2015. e-Pub 2015. PMID: 26471236.
36. Fedirko V, Bradshaw PT, Figueiredo JC, Sandler RS, Barry EL, Ahnen DJ, Milne GL, Bresalier RS, Baron JA. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS). Cancer Prev Res (Phila) 8(11):1061-8, 2015. e-Pub 2015. PMID: 26304466.
37. Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, Beck GJ, Bresalier RS, Burke CA, Church TR, Cruz-Correa M, Figueiredo JC, Goodman M, Kim AS, Robertson DJ, Rothstein R, Shaukat A, Seabrook ME, Summers RW. A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med 373(16):1519-30, 2015. e-Pub 2015. PMID: 26465985.
38. Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Hickey T, Riley T, Church TR, Weissfeld J, Schoen RE, Marcus PM, Prorok PC. Occurrence of Distal Colorectal Neoplasia Among Whites and Blacks Following Negative Flexible Sigmoidoscopy: An Analysis of PLCO Trial. J Gen Intern Med 30(10):1447-53, 2015. e-Pub 2015. PMID: 25835747.
39. Raju GS, Lum PJ, Slack RS, Thirumurthi S, Lynch PM, Miller E, Weston BR, Davila ML, Bhutani MS, Shafi MA, Bresalier RS, Dekovich AA, Lee JH, Guha S, Pande M, Blechacz B, Rashid A, Routbort M, Shuttlesworth G, Mishra L, Stroehlein JR, Ross WA. Natural language processing as an alternative to manual reporting of colonoscopy quality metrics. Gastrointest Endosc. e-Pub 2015. PMID: 25910665.
40. Figueiredo JC, Crockett SD, Snover DC, Morris CB, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Robertson DJ, Burke CA, Bresalier RS, Church JM, Church TR, Baron JA. Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control 26(3):377-86, 2015. e-Pub 2015. PMID: 25537738.
41. Ahnen DJ, Bresalier RS, Levin B, Kaunitz JD. CRC screening, past, present, and future: a tribute to Emmet Keeffe. Dig Dis Sci 60(3):589-91, 2015. e-Pub 2015. PMID: 25724168.
42. Wallace K, Burke CA, Ahnen DJ, Barry EL, Bresalier RS, Saibil F, Baron JA. The association of age and race and the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev 24(2):448-53, 2015. e-Pub 2015. PMID: 25490989.
43. Peery AF, Sandler RS, Galanko JA, Bresalier RS, Figueiredo JC, Ahnen DJ, Barry EL, Baron JA. Risk Factors for Hemorrhoids on Screening Colonoscopy. PLoS One 10(9):e0139100, 2015. e-Pub 2015. PMID: 26406337.
44. Thosani N, Rao B, Batra S, Adeyefa B, Raju GS, Bresalier RS, Banerjee S, Guha S. Diagnostic yield of third eye retroscope on adenoma detection during colonoscopy: A systematic review and meta-analysis. World Journal of Meta-Analysis 2(4):162-170, 2014. e-Pub 2014.
45. Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, Figueiredo JC, Ahnen DJ, Bresalier RS, Burke CA, Baron JA. Genetic Variants in CYP2R1, CYP24A1 and VDR Modify the Efficacy of Vitamin D3 Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial. J Clin Endocrinol Metab:jc20141389. e-Pub 2014. PMID: 25070320.
46. Kim SJ, Lee HW, Gu Kang H, La SH, Choi IJ, Ro JY, Bresalier RS, Song J, Chun KH. Ablation of galectin-3 induces p27(KIP1)-dependent premature senescence without oncogenic stress. Cell Death Differ. e-Pub 2014. PMID: 24971481.
47. Kim SJ, Wang YG, Lee HW, Kang HG, La SH, Choi IJ, Irimura T, Ro JY, Bresalier RS, Chun KH. Up-regulation of neogenin-1 increases cell proliferation and motility in gastric cancer. Oncotarget 5(10):3386-98, 2014. e-Pub 2014. PMID: 24930499.
48. Biancolella M, Fortini BK, Tring S, Plummer SJ, Mendoza-Fandino GA, Hartiala J, Hitchler MJ, Yan C, Schumacher FR, Conti DV, Edlund CK, Noushmehr H, Coetzee SG, Bresalier RS, Ahnen DJ, Barry EL, Berman BP, Rice JC, Coetzee GA, Casey G. Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1. Hum Mol Genet 23(8):2198-209, 2014. e-Pub 2014. PMID: 24256810.
49. Fortini BK, Tring S, Plummer SJ, Edlund CK, Moreno V, Bresalier RS, Barry EL, Church TR, Figueiredo JC, Casey G. Multiple Functional Risk Variants in a SMAD7 Enhancer Implicate a Colorectal Cancer Risk Haplotype. PLoS One 9(11):e111914, 2014. e-Pub 2014. PMID: 25375357.
50. Barry EL, Mott LA, Melamed ML, Rees JR, Ivanova A, Sandler RS, Ahnen DJ, Bresalier RS, Summers RW, Bostick RM, Baron JA. Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One 9(10):e108094, 2014. e-Pub 2014. PMID: 25329821.
51. Rees JR, Hendricks K, Barry EL, Peacock JL, Mott LA, Sandler RS, Bresalier RS, Goodman M, Bostick RM, Baron JA. Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial. Clin Infect Dis 57(10):1384-92, 2013. e-Pub 2013. PMID: 24014734.
52. Raju GS, Vadyala V, Slack R, Krishna SG, Ross WA, Lynch PM, Bresalier RS, Hawk E, Stroehlein JR. Adenoma detection in patients undergoing a comprehensive colonoscopy screening. Cancer Med 2(3):391-402, 2013. e-Pub 2013. PMID: 23930215.
53. Barry EL, Poole EM, Baron JA, Makar KW, Mott LA, Sandler RS, Ahnen DJ, Bresalier RS, McKeown-Eyssen GE, Ulrich CM. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment. Cancer Causes Control. e-Pub 2012. PMID: 23081681.
54. Sung JJ, Ng EK, Jt L, Ho KY, Ji JR, Sugano K, Poon RT, Chan AT, Goh KL, Han KH, Chen LL, Wu KC Ng SS, Bresalier RS, Chan FK. Digestive cancer management in Asia: Position statements: A report on GI Oncology Summit in 2011. J Gastroenterol Hepatol 27(9):1417-1422, 2012. e-Pub 2012. PMID: 22694174.
55. Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Sanderson AK, Bresalier R, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Factors Associated with Inadequate Colorectal Cancer Screening with Flexible Sigmoidoscopy. Cancer Epidemiol 36(4):395-9, 2012. e-Pub 2012. PMID: 22112544.
56. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD, Team PP. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 366(25):2345-57, 2012. e-Pub 2012. PMID: 22612596.
57. Yurgelun MB, Goel A, Hornick JL, Sen A, Turgeon DK, Ruffin MT, Marcon NE, Baron JA, Bresalier RS, Syngal S, Brenner DE, Boland CR, Stoffel EM. Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) 5(4):574-82, 2012. e-Pub 2012. PMID: 22262812.
58. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier RS, Hickey T, Riley T, Prorok PC. Colorectal Cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Gastrointestinal Endoscopy 75(3):612-20, 2012. e-Pub 2012. PMID: 22341106.
59. Mazurek N, Byrd JC, Sun Y, Hafley M, Ramirez K, Burks J, Bresalier RS. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells. Cell Death Differ 19(3):523-33, 2012. e-Pub 2012. PMID: 21941373.
60. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD, Team PP. Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination. J Natl Cancer Inst 104(4):280-9, 2012. e-Pub 2012. PMID: 22298838.
61. Song S, Ji B, Ramachandran V, Wang H, Hafley M, Logsdon C, Bresalier RS. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding ras and activating ras signaling. PLoS One 7(8):e42699, 2012. e-Pub 2012. PMID: 22900040.
62. Mazurek N, Byrd JC, Sun Y, Ueno S, Bresalier RS. A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells. Cancer 117(19):4375-80, 2011. e-Pub 2011. PMID: 21446041.
63. White WB, Bresalier R, Kaplan AP, Palmer BF, Riddell RH, Lesogor A, Chang W, Keefe DL. Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretices: a pooled analysis of clinical experience of 12,942 patients. J Clin Hypertens (Greenwich) 13(7):506-16, 2011. e-Pub 2011. PMID: 21762364.
64. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, Reding DJ, Greenlee RT, Yokochi LA, Kessel B crawford ED, Church TR, Andriole GL, Weissfeld JL, Fouad MN, Chia D, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hartge P, Pinsky PF, Zhu CS, Izmirlian G, Kramer BS, Miller AB, Xu JL, Prorok PC, Gohagan JK, Berg CD, Team PP. Effect of screening on ovairan cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA 305(22):2295-303, 2011. e-Pub 2011. PMID: 21642681.
65. Tong Z, Chakraborty S, Sung B, Koolwal P, Kaur S, Aggarwal BB, Mani SA, Bresalier RS, Batra SK, Guha S. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Cancer 117:4375-4380. e-Pub 2010. PMID: 21192057.
66. Song S, Byrd JC, Guha S, Liu KF, Koul D, Bresalier RS. Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway. Cancer. e-Pub 2010. PMID: 21157954.
67. Bresalier RS. Management of high-risk colonoscopy patients. Gastrointest Endosc Clin N Am 20(4):629-40, 2010. e-Pub 2010. PMID: 20889068.
68. White WB, Bresalier R, Kaplan AP, Palmer BF, Riddell RH, Lesogor A, Chang W, Keefe DL. Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension. J Clin Hypertens (Greenwich) 12(10):765-75, 2010. e-Pub 2010. PMID: 21029339.
69. Wong HL, Peters U, Hayes RB, Huang WY, Schatzkin A, Bresalier RS, Velie EM, Brody LC. Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer 46(13):2457-66, 2010. e-Pub 2010. PMID: 20510605.
70. Shafi MA, Bresalier RS. The gastrointestinal complications of oncologic therapy. Gastroenterol Clin North Am 39(3):629-47, 2010. e-Pub 2010. PMID: 20951921.
71. Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, Crawford ED, Kvale P, Fouad M, Hickey T, Riley T, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst 102(8):538-46, 2010. e-Pub 2010. PMID: 20357245.
72. Weston BR, Iyer RB, Qiao W, Lee JH, Bresalier RS, Ross WA. Ability of integrated positron emission and computed tomography to detect significant colonic pathology: the experience of a tertiary cancer center. Cancer 116(6):1454-61, 2010. e-Pub 2010. PMID: 20143447.
73. Waye JD, Heigh RI, Fleischer DE, Leighton JA, Gurudu S, Aldrich LB, Li J, Ramrakhiani S, Edmundowicz SA, Early DS, Jonnalagadda S, Bresalier RS, Kessler WR, Rex DK. A retrograde-viewing device improves detection of adenomas in the colon: a prospective efficacy evaluation (with videos). Gastrointest Endosc 71(3):551-6, 2010. e-Pub 2010. PMID: 20018280.
74. Ruffin MT, Normolle DP, Evelegh MJ, Baron JA, Bresalier RS, Marcon NE, Syngal S, Turgeon DK, Tuck MK, Brenner DE. Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test. Cancer Biomark 8(2):109-12, 2010. e-Pub 2010. PMID: 21896998.
75. Ho GY, Xue X, Cushman M, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Barry EL, Saibil F, Bresalier RS, Rohan TE, Baron JA. Antagonistic effects of aspirin and folic acid on inflammation markers and subsequent risk of recurrent colorectal adenomas. J Natl Cancer Inst 101(23):1650-4, 2009. e-Pub 2009. PMID: 19822838.
76. Barry EL, Sansbury LB, Grau MV, Ali IU, Tsang S, Munroe DJ, Ahnen DJ, Sandler RS, Saibil F, Gui J, Bresalier RS, McKeown-Eyssen GE, Burke C, Baron JA. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 18(10):2726-33, 2009. e-Pub 2009. PMID: 19755647.
77. Robertson DJ, Burke CA, Welch HG, Haile RW, Sandler RS, Greenberg ER, Ahnen DJ, Bresalier RS, Rothstein RI, Cole B, Mott LA, Baron JA. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med 151(2):103-9, 2009. e-Pub 2009. PMID: 19620162.
78. Bresalier RS. Early detection of and screening for colorectal neoplasia. Gut Liver 3(2):69-80, 2009. e-Pub 2009. PMID: 20431727.
79. Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, Hamdan R, Chen X, Bresalier RS, McKeown-Eyssen G, Haile RW, Baron JA, Issa JP. Global DNA Hypomethylation (LINE-1) in the Normal Colon and Lifestyle Characteristics and Dietary and Genetic Factors. Cancer Epidemiol Biomarkers Prev 18(4):1041-9, 2009. e-Pub 2009. PMID: 19336559.
80. Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD, Team PP. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13):1310-9, 2009. e-Pub 2009. PMID: 19297565.
81. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, McKeown-Eyssen GE, Baron JA. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 101(6):432-5, 2009. e-Pub 2009. PMID: 19276452.
82. Grau MV, Sandler RS, McKeown-Eyssen G, Bresalier RS, Haile RW, Barry EL, Ahnen DJ, Gui J, Summers RW, Baron JA. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst 101(4):267-76, 2009. e-Pub 2009. PMID: 19211442.
83. Song S, Mazurek N, Liu C, Sun Y, Ding QQ, Liu K, Hung MC, Bresalier RS. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity. Cancer Res 69(4):1343-9, 2009. e-Pub 2009. PMID: 19190323.
84. Song S, Krishnan K, Liu K, Bresalier RS. Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression. Clin Cancer Res 15(2):622-31, 2009. e-Pub 2009. PMID: 19147768.
85. Robertson D, Burke C, Gilbert-Welch H, Haile R, Robert S, Robert G, Ahnen D, Bresalier R, Rothstein R, Cole B, Mott L, Baron J. Estimated Risk of Advanced and Multiple Adenomas Based On the Results of Two Prior Colonoscopies. Gastroenterology 151:103-09, 2009. e-Pub 2009.
86. Andriole G, Crawford E, Grun R, et al. Mortality rates from a randomized prostate cancer screening trial. New England Journal of Medicine 360:1310-1319, 2009. e-Pub 2009.
87. Stoffel EM, Turgeon DK, Stockwell DH, Normolle DP, Tuck MK, Marcon NE, Baron JA, Bresalier RS, Arber N, Ruffin MT, Syngal S, Brenner DE, Brenner DE. Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila Pa) 1(7):507-13, 2008. e-Pub 2008. PMID: 19139000.
88. Chan FK, Abraham NS, Scheiman JM, Laine L, on Gastrointestinal FIWP, Anti-inflammatory Drugs CEON, Agents A. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol 103(11):2908-18, 2008. e-Pub 2008. PMID: 18853980.
89. Baron JA, Sandler RS, Bresalier RS, Lanas A, Morton D, Riddell R, Iverson ER, Demets, DL. Cardiovascular events associated with rofecoxib: Final Analysis of the APPROVe Trial. Lancet 372(9651):1756-64, 2008. e-Pub 2008. PMID: 18922570.
90. Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK, Bresalier RS, Marcon NE, Baron JA, Ruffin MT, Brenner DE, Syngal S, Syngal S. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila Pa) 1(6):470-5, 2008. e-Pub 2008. PMID: 19138994.
91. Figueiredo J, Levine J, Grau M, Barry E, Ueland PM, Ahnen D, Byers T, Bresalier R, Syummers R, j B, Eyssen G, Sandler R, Haile R, Baron J. Colorectal Adenomas in a Randomized Folate Trial: The Role of Baseline Dietary and Circulating Folate Levels. Cancer Epidemiol Biomarkers Prev 17(10):2625-31, 2008. e-Pub 2008. PMID: 18843003.
92. Bresalier RS. Barrett's esophagus and esophageal adenocarcinoma. Annu Rev Med. e-Pub 2008. PMID: 18783330.
93. Qiu Y, Patwa TH, Xu L, Shedden K, Misek DE, Tuck M, Jin G, Ruffin MT, Turgeon DK, Synal S, Bresalier R, Marcon N, Brenner DE, Lubman DM. Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res 7(4):1693-703, 2008. e-Pub 2008. PMID: 18311904.
94. Tong Z, Kunnumakkara AB, h W, Matsuo Y, Diagaradjane P, Harikumar KB, Ramachandran V, Sung B, Chakraborty A, Bresalier RS, Logsdon C, Aggarwal BB, Krishnan S, and Guha S. Neutrophil Gelatinase-Associated Lipocalin: A Novel Suppressor of Invasion and Angiogenesis in Pancreatic Cancer. Cancer Res 68(15):6100-6108, 2008. e-Pub 2008. PMID: 18676832.
95. Dixon LB, Subar AF, Peters U, Weissfeld JL, Bresalier RS, Risch A, Schatzkin A, Hayes RB. Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma. J Nutr 137(11):2443-50, 2007. e-Pub 2007. PMID: 17951483.
96. Mazurek N, Sun YJ, Liu KF, Gilcrease MZ, Schober W, Nangia-Makker P, Raz A, Bresalier RS. Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells. J Biol Chem 282(29):21337-48, 2007. e-Pub 2007. PMID: 17420249.
97. Song S, Guha S, Liu K, Buttar NS, Bresalier RS. COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma. Gut 56(11):1512-21. e-Pub 2007. PMID: 17604323.
98. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon N, Saibil F, Ueland PM, Greenberg ER, Greenberg ER. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297(21):2351-9, 2007. e-Pub 2007. PMID: 17551129.
99. Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer 109(4):668-74, 2007. e-Pub 2007. PMID: 17211862.
100. Lanas A, Baron JA, Sandler RS, Horgan K, Bolognese J, Oxenius B, Quan H, Watson D, Cook TJ, Schoen R, Burke C, Loftus S, Niv Y, Ridell R, Morton D, Bresalier R. Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma chemoprevention trial. Gastroenterology 132(2):490-7, 2007. e-Pub 2007. PMID: 17258718.
101. Lanas A, Baron J, Sandler R, Horgan K, Bolognes J, Oxenious B, Quan H, Watson D, Schoen R, Burke C, Loftus S, Niv Y, Riddell R, Morton D, Bresalier RS. Upper gastrointestinal ulcer and bleeding events associated with rofecoxib in a 3-year randomized colorectal adenoma chemoprevention trial. Gastroenterology 132:490-497, 2007. e-Pub 2007.
102. Baron JA, Sandler RS, Bresalier RS, Quan H, Riddell R, Lanas A, Bolognese JA, Oxenius B, Horgan K, Loftus S, Morton DG. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131:1674-82, 2006. e-Pub 2006. PMID: 17087947.
103. Flood A, Peters U, Jenkins DJA, Chatterjee N, Subar AF, Church TR, Bresalier RS, Weissfeld JL, Shatzkin A, Hayes RB. Carbohydrate, glycemic load and colorectal adenomas in the PLCO Screening Study. Am J Clin Nutr 131:1184-1192, 2006. e-Pub 2006.
104. Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan C, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal B, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Eans AA, Blot WJ, W-H C, Blount PL, Maley CC, Wang KK, Lee JJ, Dubinett SM, Engstrom PF, Meyskens Jr FL, Ransohoff DF, Hawk ET, Levin B, Nelson WG, and Hong WK. Progress in chemoprevention drug development: The promise of molecular biomarkers for cancer prevention and treatment and prevention of intraepithelial neoplasia (IEN)A Plan to Move Forward (AACR Cancer Prevention Task Force). Clin Cancer Res 12:3661-3697, 2006. e-Pub 2006.
105. Huang WY, Berndt SI, Kang D, Chatterjee N, Yeager M, Welch R, Bresalier RS, Weissfeld J, Hayes R. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related history. Cancer Epidemiol Biomarkers Prev 15:306-311, 2006. e-Pub 2006.
106. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporiciyan AA, Walsh GA, Lahoti S, Lee JH, Bresalier RS, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131:65-72, 2006. e-Pub 2006.
107. Luthra R, Wu TT, Luthra M, Izzo J, Lopez-Alvarez M Bailey J, Lee JH, Bresalier R, Rashid A, Swisher S, Ajani J. Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol 24:259-267, 2006. e-Pub 2006.
108. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092-102, 2005. e-Pub 2005. PMID: 15713943.
109. Bresalier RS, Friedwald VE, Rakel RR, Roberts WC, Williams GW. Non-steroidal anti-inflammatory drugs and cardiovascular risk. American Journal of Cardiology 96:1889-1904, 2005. e-Pub 2005.
110. Izzo JG, Malhotra U, Wu TT, Ensor J, Babenko IM, Swisher SG, Correa A, Bresalier RS, Hittelman WN, Ajani J. Impact of cyclin D1 A870G polymorphism in esophageal carcinoma tumorigenesis. Semin Oncol 32, Suppl:11-15, 2005. e-Pub 2005.
111. Hong D, Lunagomez S, Kim E, Lee J, Bresalier RS, Swisher S, Wu T, Morris J, Liao Z, Komaki R, Ajani A. Value of baseline positron emission tomography for prediting overall survival in patients with non-metastatic esophageal or gastroesophageal junction carcinoma. Cancer 104:1620-1626, 2005. e-Pub 2005.
112. Song S, Byrd JC, Liu KF, Kou JP, Bresalier RS. Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription through AP-1 activation. Gastroenterology 129:1581-1591, 2005. e-Pub 2005.
113. Weiser MA, Cabanillas M, Vu K, Tamm E, Wallace J, Escalante CP, Bresalier RS. Diagnostic evaluation of patients with a high suspicion of malignancy; co-morbidities, and clinical predictors of cancers. The Am J Med Sci 330:11-18, 2005. e-Pub 2005.
114. Hou L, Chatterjee N, Huang WY, Baccarelli A, Yadavalli S, Yeager M, Bresalier RS, Chanock SJ, Caporaso NE, Ji BT, Weissfeld JL, Hayes RB. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. Carcinogenesis 26:1122-8, 2005. e-Pub 2005. PMID: 15731166.
115. Robertson DJ, Greenberg ER, Beach M, Sandler RS, Ahnen D, Haile RW, Burke CA, Snover DC, Bresalier RS, McKeown-Eyssen G, Mandel JS, Bond JH, Van Stolk RU, Summers RW, Rothstein R, Church TR, Cole BF, Byers T, Mott L, Baron JA. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 129:34-41, 2005. e-Pub 2005. PMID: 16012932.
116. Song S, Byrd JC, Koo JS, Bresalier RS. Bile acids induce MUC2 overexpression in human colon carcinoma cells. Cancer 103:1606-14, 2005. e-Pub 2005. PMID: 15754327.
117. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, Austin JH, Prorok PC, Gohagan JK. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 97:989-97, 2005. e-Pub 2005. PMID: 15998952.
118. McGlynn KA, Sakoda LC, Hu Y, Schoen RE, Bresalier RS Yeager M, Chanock S, Hayes RB, Buetow KH. Hemochromatosis gene mutations and distal adenomatous polyps. Cancer Epidemol Biomarkers Prev 12:158-63, 2005. e-Pub 2005.
119. Mazurek N, Sun YJ, Price JE, Ramdas L, Schoen W, Nangia Makker P, Raz A, Bresalier, RS. Phosphorylation of galectin-3 is a pre-requisite for malignant transformation of human breast epithelial cells through modulation of a unique set of genes. Cancer, 2005. e-Pub 2005.
120. Holt P, Bresalier RS, Ma CK, K-F L, Lipkin M, Yang K. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer, 2005. e-Pub 2005.
121. Rohatgi PR, Swisher S, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporicyan A, Rice D, Bresalier RS, Roth J, Ajani J. Histologic subtypes as determinants of outcome in esophageal cancer patients with pathologic responses after preoperative chemoradiation. Cancer, 2005. e-Pub 2005.
122. Bresalier RS, Byrd JC, Tessler D, Lebel J, Koomen J, Hawke D, Half E, Liu KF, Mazurek N. A circulating ligand for galectin-3 is a haptoglobin-related glycoprotein elevated in individuals with colon cancer. Gastroenterology 127:741-8, 2004. e-Pub 2004. PMID: 15362030.
123. Lao CD, Simmons M, Syngal S, Bresalier RS, Fortlage L, Normolle D, Griffith KA, Appelman HD, Brenner DE. Dysplasia in Barrett esophagus. Cancer 100:1622-7, 2004. e-Pub 2004. PMID: 15073848.
124. Peters U, Chatterjee N, McGlynn KA, Schoen RE, Church TR, Bresalier RS, Gaudet MM, Flood A, Schatzkin A, Hayes RB. Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. Am J Clin Nutr 80:1358-65, 2004. e-Pub 2004. PMID: 15531687.
125. Sternberg LR, Byrd JC, Hansson GC, Liu KF, Bresalier RS. Alternative splicing of the human MUC2 gene. Arch Biochem Biophys 421(1):21-33, 2004. e-Pub 2004. PMID: 14678781.
126. Takenaka Y, Fukumori T, Yoshii T, Oka N, Inohara H, Kim, RRC, Bresalier RS, Raz A. Phosphorylation of the N-terminal domain of galectin-3 regulates its cellular localization and anti-apoptotic function in response to chemotherapeautic drugs,. Mol Cell Biol 24:4395-4406, 2004. e-Pub 2004.
127. Peters U, Sinha R, Chatterjee N, Subar AF, Ziegler RG, Kulldorff M, Bresalier R, Weissfeld JL, Flood A, Schatzkin A, Hayes RB. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet 361:1491-5, 2003. e-Pub 2003. PMID: 12737857.
128. Schoen RE, Pinsky PF, Weissfeld JL, Bresalier RS, Church T, Prorok P, Gohagan JK. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 290:41-8, 2003. e-Pub 2003. PMID: 12837710.
129. Pinsky PF, Schoen RE, Weissfeld JL, Bresalier RS, Hayes RB, Gohagan JK. Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy. Clin Gastroenterol Hepatol 1:103-10, 2003. e-Pub 2003. PMID: 15017502.
130. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891-9, 2003. e-Pub 2003. PMID: 12621133.
131. Weissfeld JL, Ling BS, Schoen RE, Bresalier RS, Riley T, Prorok PC. Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer 94:2569-76, 2002. e-Pub 2002. PMID: 12173322.
132. Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst 94:1854-62, 2002. e-Pub 2002. PMID: 12488479.
133. Dudas SP, Yunker CK, Sternberg LR, Byrd JC, Bresalier RS. Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancer. Gastroenterology 123:817-26, 2002. e-Pub 2002. PMID: 12198708.
134. Mazurek N, Conklin J, Byrd JC, Raz A, Bresalier RS. Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. J Biol Chem 275(46):36311-5, 2000. e-Pub 2000. PMID: 10961987.
135. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21:273S-309S, 2000. e-Pub 2000. PMID: 11189684.
136. Byrd JC, Bresalier RS. Alterations in gastric mucin synthesis by Helicobacter pylori. World J Gastroenterol 6:475-482, 2000. e-Pub 2000. PMID: 11819633.
137. Byrd JC, Yunker CK, Xu QS, Sternberg LR, Bresalier RS. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology 118:1072-9, 2000. e-Pub 2000. PMID: 10833482.
138. Barcina MG, Solaun M, Riddaurrazaga J, Bresalier RS, Vidal Vanaclocha F. Colon carcinoma and sinusoidal endothelial cells release mutual adhesion-stimulating factors promoting experimental hepatic metastasis in a murine model. Cells of the Hepatic Sinusoids 17:286-7, 1999. e-Pub 1999.
139. Sternberg LR, Byrd JC, Yunker CK, Dudas S, Hoon VK, Bresalier RS. Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis. Gastroenterology 116:363-71, 1999. e-Pub 1999. PMID: 9922317.
140. Gong HC, Honjo Y, Nangia-Makker P, Hogan V, Mazurak N, Bresalier RS, Raz A. The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Res 59:6239-45, 1999. e-Pub 1999. PMID: 10626818.
141. Carethers JM, Chauhan DP, Fink D, Nebel S, Bresalier RS, Howell SB, Boland CR. Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology 117:123-31, 1999. e-Pub 1999. PMID: 10381918.
142. Zielke A, Bresalier RS, Siperstein AE, Clark OH, Rothmund M, Duh QY. A unique allogenic model of metastatic pheochromocytoma: PC12 rat pheochromocytoma xenografts to nude mice and establishment of metastases-derived PC12 variants. Clin Exp Metastasis 16:341-52, 1998. e-Pub 1998. PMID: 9626813.
143. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology 115:287-96, 1998. e-Pub 1998. PMID: 9679034.
144. Bresalier RS, Byrd JC, Brodt P, Ogata S, Itzkowitz SH, Yunker CK. Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length. Int J Cancer 76:556-62, 1998. e-Pub 1998. PMID: 9590134.
145. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80(4):776-87, 1997. e-Pub 1997. PMID: 9264362.
146. Fazeli A, Steen RG, Dickinson SL, Bautista D, Dietrich WF, Bronson RT, Bresalier RS, Lander ES, Costa J, Weinberg RA. Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas. Proc Natl Acad Sci U S A 94:10199-204, 1997. e-Pub 1997. PMID: 9294187.
147. Byrd JC, Yan P, Sternberg L, Yunker CK, Scheiman JM, Bresalier RS. Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology 113:455-64, 1997. e-Pub 1997. PMID: 9247464.
148. Brodt P, Fallavollita L, Bresalier RS, Metrissian S, Norton CR, Wolitzky BA. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 71:612-9, 1997. e-Pub 1997. PMID: 9178816.
149. Bresalier RS, Byrd JC, Wang L, Raz A. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. Cancer Res 56:4354-7, 1996. e-Pub 1996. PMID: 8813123.
150. Bresalier RS, Ho SB, Schoeppner HL, Kim YS, Sleisenger MH, Brodt P, Byrd JC. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 110:1354-67, 1996. e-Pub 1996. PMID: 8613039.
151. Schoeppner HL, Raz A, Ho SB, Bresalier RS. Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer 75:2818-26, 1995. e-Pub 1995. PMID: 7773932.
152. Schoeppner HL, Wong DK, Bresalier RS. Primary small bowel lymphoma manifested as obstructive jaundice in a patient with AIDS. South Med J 88:583-5, 1995. e-Pub 1995. PMID: 7732453.
153. Qi Y, Moyana T, Matte G, Wilkinson A, Bresalier R, Xiang J. Immunolocalization of hepatic metastases of human colonic cancer by chimeric anti-TAG72 antibody in SCID mice. J Surg Oncol 59:3-9, 1995. e-Pub 1995. PMID: 7745973.
154. Qi Y, Moyana T, Bresalier R, Xiang J. Antibody-targeted lymphokine-activated killer cells inhibit liver micrometastases in severe combined immunodeficient mice. Gastroenterology 109:1950-7, 1995. e-Pub 1995. PMID: 7498661.
155. Bresalier RS, Schwartz B, Kim YS, Duh QY, Kleinman HK, Sullam PM. The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells. Cancer Res 55:2476-80, 1995. e-Pub 1995. PMID: 7758002.
156. Boland CR, Sato J, Appelman HD, Bresalier RS, Feinberg AP. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat Med 1:902-9, 1995. e-Pub 1995. PMID: 7585215.
157. Ben-Menachem T, Fogel R, Patel RV, Touchette M, Zarowitz BJ, Hadzijahic N, Divine G, Verter J, Bresalier RS. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. A randomized, controlled, single-blind study. Ann Intern Med 121:568-75, 1994. e-Pub 1994. PMID: 8085688.
158. Schwartz B, Bresalier RS, Kim YS. The role of mucin in colon-cancer metastasis. Int J Cancer 52:60-5, 1992. e-Pub 1992. PMID: 1323540.
159. Rafiee P, Ho SB, Bresalier RS, Bloom EJ, Kim JH, Kim YS. Characterization of the cytokeratins of human colonic, pancreatic, and gastric adenocarcinoma cell lines. Pancreas 7:123-31, 1992. e-Pub 1992. PMID: 1372735.
160. Bresalier RS, Niv Y, Byrd JC, Duh QY, Toribara NW, Rockwell RW, Dahiya R, Kim YS. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 87:1037-45, 1991. e-Pub 1991. PMID: 1999484.
161. Gabizon A, Price DC, Huberty J, Bresalier RS, Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res 50(19):6371-8, 1990. e-Pub 1990. PMID: 1698120.
162. Bresalier RS, Rockwell RW, Dahiya R, Duh QY, Kim YS. Cell surface sialoprotein alterations in metastatic murine colon cancer cell lines selected in an animal model for colon cancer metastasis. Cancer Res 50:1299-307, 1990. e-Pub 1990. PMID: 2297775.
163. Boland CR, Bresalier RS, Roberts JA. Assay of lectin binding sites in colon cancer-associated mucins: comparison of fluorescence microscopy with a quantitative chromatographic technique. J Histochem Cytochem 36:1329-34, 1988. e-Pub 1988. PMID: 3138308.
164. Bresalier RS, Raper SE, Hujanen ES, Kim YS. A new animal model for human colon cancer metastasis. Int J Cancer 39:625-30, 1987. e-Pub 1987. PMID: 3032811.
165. Bresalier RS, Hujanen ES, Raper SE, Roll FJ, Itzkowitz SH, Martin GR, Kim YS. An animal model for colon cancer metastasis: establishment and characterization of murine cell lines with enhanced liver-metastasizing ability. Cancer Res 47:1398-406, 1987. e-Pub 1987. PMID: 3028609.
166. Bresalier RS, Grendell JH, Cello JP, Meyer AA. Sucralfate suspension versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med 83:110-6, 1987. e-Pub 1987. PMID: 3499074.
167. Bresalier RS, Boland CR, Kim YS. Regional differences in normal and cancer-associated glycoconjugates of the human colon. J Natl Cancer Inst 75:249-60, 1985. e-Pub 1985. PMID: 3927049.
168. Bresalier RS, Boland CR, Kim YS. Characteristics of colorectal carcinoma cells with high metastatic potential. Gastroenterology 87:115-22, 1984. e-Pub 1984. PMID: 6724253.
169. Strayer DS, Gutwein MB, Herbold D, Bresalier R. Histoplasmosis presenting as the carpal tunnel syndrome. Am J Surg 141:286-8, 1981. e-Pub 1981. PMID: 7457752.
170. Bresalier RS, Karlin DA. Meningeal metastasis from rectal carcinoma with elevated cerebrospinal fluid carcinoembryonic antigen. Dis Colon Rectum 22:216-7, 1979. e-Pub 1979. PMID: 223819.
171. Bresalier RS, Rizzino AA, Freundlich M. Reduced maximal levels of derepression of the isoleucine-valine and leucine enzymes in hisT mutants of Salmonella typhimurium. Nature 253:279-80, 1975. e-Pub 1975. PMID: 1089896.
172. Rizzino AA, Bresalier RS, Freundlich M. Derepressed levels of the isoleucine-valine and leucine enzymes in his T 1504, a strain of Salmonella typhimurium with altered leucine transfer ribonucleic acid. J Bacteriol 117:449-55, 1974. e-Pub 1974. PMID: 4359646.

Invited Articles

1. Cramer P, Bresalier RS. Gastrointestinal and hepatic complications of immune-modulatiry check point inhibitors. Current Gastroenterology Reports, 2017. e-Pub 2017. PMID: 28124291.
2. Bresalier RS. Early Detection and Screening for Colorectal Neoplasia-Making Sense of the Guidelines. Colorectal Cancer Treatment Reports 6(4):177-179, 2010. e-Pub 2010.
3. Bresalier RS. Chemoprevention of colorectal neoplasia: advances and controversies (the COX-2 story). Curr Opin Gastroenterol 23(1):44-7, 2007. e-Pub 2007. PMID: 17133084.
4. Bresalier RS. Barrett's Metaplasia: Defining the Problem. Seminars in Oncology 32 6 Suppl 8:21-24, 2005. e-Pub 2005.
5. Bresalier RS. Management of Barrett's Esophagus. Cases and Questions. Seminars in Oncology 2 (/suppl 9):2-5, 2005. e-Pub 2005.
6. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer and Metastasis Reviews 23:77-99, 2004. e-Pub 2004.
7. Half EE, Bresalier RS. Clinical management of hereditary colorectal cancer syndromes. Curr Opin Gastroenterol 20:32-42, 2004. e-Pub 2004. PMID: 15703618.
8. Bresalier RS. Prophylaxis for stress-related gastrointestinal hemorrhage. Current Treatment Options in Gastroenterology 2:313-319, 1999. e-Pub 1999.
9. Bresalier RS. Mucins and mucin binding proteins in colon cancer metastasis. World J Gastroenterology 4:54-59, 1998. e-Pub 1998.
10. Bresalier RS. The biology of colorectal cancer metastasis. Gastroenterol Clin North Am 25:805-20, 1996. e-Pub 1996. PMID: 8960894.
11. Bresalier RS. Adhesion molecules and gastrointestinal malignancies. Gastroenterology 106:1378-82, 1994. e-Pub 1994. PMID: 8174898.
12. Bresalier RS. Prophylaxis of stress-related gastric mucosal hemorrhage: a critical appraisal. J Intensive Care Med 5:5-6, 1990. e-Pub 1990.
13. Bresalier RS, Kim YS. Diet and colonic cancer: putting the puzzle together. N Engl J Med 313:1413-4, 1985. e-Pub 1985. PMID: 2997610.

Review Articles

1. Wei, D, Wang, L, Liu, Y, Zuo, X, Shen, X, Bresalier, R. CAR-Macrophage Cell Therapy. Clinical Cancer Research 31(19):4018-4031, 2025. e-Pub 2025. PMID: 40757874.
2. Young, G, Benton, S, Bresalier, R, Chiu, HM, Dekker, E, Fraser, CG, Frasa, MA, Halloran, S, Hoffmeister, M, Parry, S, Selby, K, Senore, C, Singh, H, Symonds, EL. Fecal Immunochemical Test Positivity Thresholds. Digestive diseases and sciences 70(5):1637-1645, 2025. e-Pub 2025. PMID: 39528850.
3. Turgeon, DK, Krammes, L, Mahmood, HN, Frondorf, F, Königs, V, Luther, J, Schölz, C, Becker, P, Maharjan, S, Sever, A, Garapati, S, Balasubramaniam, A, Knabe, M, Sharma, G, Pham, T, Preywisch, R, Eidens, M, Bresalier, R, Dollinger, M. A novel, noninvasive, multimodal screening test for the early detection of precancerous lesions and colorectal cancers using an artificial intelligence–based algorithm. Journal of Clinical Oncology 42:3627, 2024. e-Pub 2024.
4. Grizzi F, Spadaccini M, Chiriva-Internati M, MAAA H, Bresalier RS, Hassan C, Repici A, Carrara S. Fractal nature of human gastrointestinal system: Exploring a new era. World J Gastroenterol 29(25):4036-4052, 2023. e-Pub 2023. PMID: 37476585.
5. Menter DG, Bresalier RS. An Aspirin a Day: New Pharmacological Developments and Cancer Chemoprevention. Annu Rev Pharmacol Toxicol 63:165-186, 2023. e-Pub 2023. PMID: 36202092.
6. Wei D, Wang L, Zuo X, Bresalier RS. Vitamin D: Promises on the Horizon and Challenges Ahead for Fighting Pancreatic Cancer. Cancers (Basel) 13(11), 2021. e-Pub 2021. PMID: 34072725.
7. Taverna G, Di Francesco S, Borroni EM, Yiu D, Toniato E, Milanesi S, Chiriva-Internati M, Bresalier RS, Zanoni M, Vota P, Maffei D, Justich M, Grizzi F. The kidney, COVID-19, and the chemokine network: an intriguing trio. Int Urol Nephrol 53(1):97-104, 2021. e-Pub 2021. PMID: 32720031.
8. Cramer P, Bresalier RS. Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors. Curr Gastroenterol Rep 19(1):3, 2017. e-Pub 2017. PMID: 28124291.
9. Bresalier RS. Flexible sigmoidoscopy: more than a unilateral breast exam?. Dig Dis Sci 60(3):634-8, 2015. e-Pub 2015. PMID: 25740557.
10. Bresalier RS, Kopetz S, Brenner DE. Blood-based tests for colorectal cancer screening: do they threaten the survival of the FIT test?. Dig Dis Sci 60(3):664-71, 2015. e-Pub 2015. PMID: 25680874.
11. Turner ND, Ritchie LE, Bresalier RS, Chapkin RS. The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis. Curr Gastroenterol Rep 15(9):346, 2013. e-Pub 2013. PMID: 23949252.
12. Davila M, Bresalier RS. Gastrointestinal complications of oncologic therapy. Nat Clin Pract Gastroenterol Hepatol 5(12):682-96. e-Pub 2008. PMID: 18941434.
13. Bresalier RS. Chemoprevention of colorectal cancer: why all the confusion?. Curr Opin Gastroenterol 24(1):48-50, 2008. e-Pub 2008. PMID: 18043232.
14. Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78:1152-60; discussion 1152-60, 2004. e-Pub 2004. PMID: 15464463.
15. Ben-Menachem T, McCarthy BD, Fogel R, Schiffman RM, Patel RV, Zarowitz BJ, Nerenz DR, Bresalier RS. Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis. Crit Care Med 24:338-45, 1996. e-Pub 1996. PMID: 8605811.
16. Bresalier RS. The clinical significance and pathophysiology of stress-related gastric mucosal hemorrhage. J Clin Gastroenterol 13 Suppl 2:S35-43, 1991. e-Pub 1991. PMID: 1885901.

Other Articles

1. Young, G, Benton, S, Bresalier, R, Chiu, HM, Dekker, E, Fraser, CG, Frasa, MA, Halloran, S, Hoffmeister, M, Parry, S, Selby, K, Senore, C, Singh, H, Symonds, EL Correction to. Digestive diseases and sciences 70(5):1646-1647, 2025. PMID: 40067549.

Editorials

1. Bresalier RS. Colorectal Cancer. Diagnosis and Clinical Management, 2015.
2. Bresalier R. Gastrointestinal oncology: A critical multi-disciplinary team approach. Gastroenterology, 2010.
3. Bresalier, RS. The biology of cancer (book review). Gastroenterology 133:364-365, 2007.
4. Bresalier, RS. Endoscopic Oncology: Gastrointestinal endoscopy and cancer management (book review). Gastoenterology 132:2614-2616, 2007.
5. Bresalier RS. Aspirin and the prevention of colorectal neoplasia. Gastroenterology 125:1539-1541, 2003.
6. Bresalier, Robert S. Editorial Overview. Current Opinion in Gastroenterology 19:42-43, 2003.
7. Bresalier RS. Primary chemoprevention of familial adenomatous polyposis with sulindac: more questions than answers. Gastroenterology 123:379-81, 2002. PMID: 12105867.
8. Bresalier, Robert S. Editorial Overview. Current Opinion in Gastroenterology 18:51-52, 2002.
9. Bresalier, Robert S. Intestinal mucin and colon cancer. Gastroenterology 123:648-649, 2002.
10. Bresalier RS. Chemoprevention of intestinal polyposis by COX-2 inhibition: from mouse to man. Gastroenterology 122:234-6, 2002. PMID: 11781300.
11. Bresalier, Robert S. Editorial Overview. Current Opinion in Gastroenterology 17:63-64, 2001.
12. Bresalier RS. Chemoprevention comes to clinical practice: COX-2 inhibition in familial adenomatous polyposis. Gastroenterology 119:1797-8, 2000. PMID: 11113106.
13. Bresalier RS. Large intestine. Curr Opin Gastroenterol 16:61, 2000. PMID: 17024018.
14. Bresalier RS. Diagnostic testing after fecal occult blood testing: compliance is the issue. Gastroenterology 118:980-1, 2000. PMID: 10784601.
15. Bresalier RS. Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer: Are We There yet?. Gastroenterology 118:230-1, 2000. PMID: 10611174.
16. Bresalier, Robert S. Editorial Overview. Current Opinion in Gastroenterology 16:61-62, 2000.
17. Bresalier RS. Prevention of colorectal cancer: tumor progression, chemoprevention, and COX-2 inhibition. Gastroenterology 119:267-8, 2000. PMID: 10889181.
18. Bresalier RS. Transforming growth factor beta and tumor-suppressing pathways: it doesn't matter how you get there, as long as you get there. Gastroenterology 117:500-2, 1999. PMID: 10419934.
19. Bresalier RS, Ho SB. Molecular staging of colorectal cancer: a step forward. Gastroenterology 116:769, 1999. PMID: 10029636.
20. Bresalier RS. Calcium, chemoprevention, and cancer: a small step forward (a long way to go). Gastroenterology 116:1261-3, 1999. PMID: 10220522.
21. Bresalier RS. Tumor progression in the intestine: smad about you. Gastroenterology 115:1598-9, 1998. PMID: 9834295.
22. Bresalier, Robert S. DNA mismatch repair and colorectal cancer: of mice and men. Gastroenterology 115:789-790, 1998.
23. Bresalier, Robert S. The American Cancer Society Guidelines for Colorectal Cancer Screening. Have we gone too far (or not far enough)?. Gastroenterology 114:1341-1343, 1998.
24. Bresalier RS. Helicobacter pylori and gastric cancer: a not so simple association. Gastroenterology 114:408-9, 1998. PMID: 9453504.
25. Bresalier, Robert S. Prophylaxis for stress-related upper gastrointestinal bleeding: something old and something new. Advances in Gastroenterology, Hepatology and Clinical Nutrition 3:245-248, 1998.
26. Bresalier RS. The gatekeeper has many keys: dissecting the function of the APC gene. Gastroenterology 113:2009-10, 1997. PMID: 9394744.
27. Bresalier R. Fecal occult blood testing: beyond hemoccult. Gastroenterology 112:664-5, 1997. PMID: 9024324.
28. Bresalier RS. In search of a better aspirin: suppression of intestinal polyposis by targeted inhibition of cyclooxygenase 2. Gastroenterology 113:1039-40, 1997. PMID: 9288002.

Abstracts

1. Bresalier RS, Souza RF. A Goblet (Cell) Half Full: What Do We Really Know About Barrett's Esophagus-A Tribute to Emmet Keeffe. Dig Dis Sci 63(8):1985-1987, 2018. e-Pub 2018. PMID: 29948560.
2. Bresalier RS. Chemoprevention of Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci 63(8):2155-2162, 2018. e-Pub 2018. PMID: 29948566.
3. Passarelli MN, Barry EL, Zhang D, Gangar P, Rees JR, Bresalier RS, McKeown-Eyssen G, Karagas MR, Baron JA. Risk of basal cell carcinoma in a randomized clinical trial of aspirin and folic acid for the prevention of colorectal adenomas. Br J Dermatol 179(2):337-344, 2018. e-Pub 2018. PMID: 29570772.
4. Crockett SD, Barry EL, Mott LA, Ahnen DJ, Robertson DJ, Anderson JC, Wallace K, Burke CA, Bresalier RS, Figueiredo JC, Snover DC, Baron JA. Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial. Gut. e-Pub 2018. PMID: 29496722.
5. Bresalier RS, Byrd JC, Brenner DE, Nielsen HJ, Feng Z, Liu S, Hanash S, Taguchi A, Baron JA, Syngal S, Tuck M, Davis G. A blood-based marker panel for detection of colorectal neoplasia. Innovations in cancer Prevention and Research Conference Program and Abstracts (CPRIT) 301:110, 2017. e-Pub 2017.
6. Huo X, Zhand X, Yu C, Cheng E, Zhang QD, Dunbar KB, Pham T, Lynch JP, Wang DH, Bresalier RS, Spechler SJ, Souza RF. Asprin prevents NF-ΚB activation and CDX2 expression induced by acid and bile salts in esophageal squamous cells of patients with Barrett’s esophagus. Gastroenterology 5:S-233, 2017. e-Pub 2017.
7. Bresalier RS, Byrd JC, Brenner DE, Nielsen HJ, Feng Z, Liu S, Hanash S, Taguchi A, Baron JA, Syngal S, Tuck M, Davis G. A blood-based marker panel for detection of colorectal neoplasia. Gastroenterology 5:S-1316, 2017. e-Pub 2017.
8. Pedersen N, Marielle Herzog M, Martens F, Bresalier R, Micallef J, Davis G, Jarle Christensen I, Nielsen HJ. Colorectal cancer associated biomarkers-effect of bowel preparation. ISOBM Proceedings, 2016. e-Pub 2016.
9. Bresalier RS. Screening and early detection of colorectal cancer. Asia Pacific Digestives Diseases Week, 2015. e-Pub 2015.
10. Bresalier RS, Byrd JC, Chia D, Feng Z, Hanash S. Blood-based biomarkers for screening and detection of colorectal cancer. Innovations in Cancer Prevention and Research Conference (CPRIT)(A203), 2015. e-Pub 2015.
11. Raju GS, Lum P, Lynch P, Davila M, Ross W, Bhutani M, Miller E, Lee JH, Shafi M, Thirumurthi S, Weston B, Bresalier RS, Shuttlesworth G, Mishra L, Stroehlein J. Outcome of management of colon polyps larger than 20 mm at a referral endoscopic mucosal resection center. Gastroenterology, 2015. e-Pub 2015.
12. Thirumurthi S, Ross W, Lum P, Pande M, Miller E, Lee JH, Weston B, Lynch P, Davila M, Bhutani M, Shafi M, Blechacz B, Bresalier RS, Stroehlein J, Mishra L, Faju GS. When patients watch a video, physicians see more adenoma: An educational bowel preparation video improves adenoma detection rates. Gastroenterology, 2015. e-Pub 2015.
13. Miller E, Thirumurthi S, Lum P, Pande M, Ross WA, Davila M, Weston B, Blechacz B, Bhutani M, Lee JH, Lynch P, Shafi M, Bresalier RS, Mishra L, Stroehlein J, Raju GS. Five year trends in adenoma detection rates: A report from a single academic group practice. Gastroenterology, 2015. e-Pub 2015.
14. Slack RS, Ross WA, Lum P, Thirumurthi S, Weston BR, Miller E, Lee JH, Shafi M, Davila ML, Bresalier RS, Lynch PM, Shuttlesworth G, Mishra L, Stroehlein J, Raju GS. Reporting adenoma detection rate confidence intervals provides better feedback about endoscopist's performance. Gastroenterology, 2015. e-Pub 2015.
15. Faju GS, Lum P, Serna MK, Ross WA, Lynch PM, Thirumurthi S, Lee JH, Miller E, Bhutani M, Rasid A, Shafi M, Weston B, Bresalier RS Shutlesworth G, Mishra L, Stroehlein J. Outcome of referral to an endoscopic mucosal resection center as an alternative to surgery in patients with large and flat colon tumors. Gastroenterology, 2015. e-Pub 2015.
16. Bresalier RS, Byrd JC, Feng Z, Brenner D, Hanash S. Blood-based biomarkers for screening and early detection of colorectal neoplasia. Innovations in Cancer Prevention Research Conference (CPRIT), 2015. e-Pub 2015.
17. Thirumurthi S, Ross W, Lum P, Weston B, Pande M, Lynch P, Shafi M, Bhutani M, Dekovich A, Lee JH, Davila M, Bresalier RS, et al. Adenoma detection rate and sessile adenoma detection rate trends with increasing age: a study using natrual language processing computer program. Gstroenterology, Digestive Diseases Week, 2014. e-Pub 2014.
18. Miller E, Ross W, Thirumurthi S, Weston B, Bhutani M, Blechacz B, Bresalier RS, et al. Screening colonoscopy quality metrics for males and females across ethnic groups using a natural language processing algorithm. Gastroenterology, Digestive Diseases Week, 2014. e-Pub 2014.
19. Raju GS, Ross W, Lum P, Lynch P, Slack R, Miller E, Weston B, Davila M, Thirumurthi S, Shafi M, Bresalier RS, et al. Natural language processing (NLP) as an alternative to manual reporting of colonoscopy quality metrics. Gastroenterology, Digestive Diseases Week, 2014. e-Pub 2014.
20. Weston B, Ross W, Lum P, Thirumurthi S, Miller E, Bhutani M, Blechacz B, Bresalier RS, et al. Adenoma detection rate (ADR) and serrated adenoma detection rate (Sdr) during screening colonoscopy with and without personal cancer history (Pch) in a teriatry referral cancer center. Gastroenterology, Digestive Diseases Week, 2014. e-Pub 2014.
21. Baron JA, Barry EL, Burke CA, Bostick R, Bresalier RS, et al. A clinical trial of supplementation of vitamin D and calcium for prevention of colorectal neoplasia. Proc Am Assoc Cancer Res, 2014. e-Pub 2014.
22. Illmer M, Mazurek N, Byrd JC Vykolal J, Bresalier RS. Low surface Gal3 expression in breast cancer cells is associated with chemoresistance, tumorigenesis and decreased overall patient survival. Proc Am Assoc Cancer Res, 2014. e-Pub 2014.
23. Bresalier RS. A circulating ligand for galectin-3 elevated in the serum of individuals with colorectal neoplasia. Texas FreshAIR Academia Industry Roundtable, University of Texas, Austin, 2013. e-Pub 2013.
24. Laiyemo A, Izmirlian G, Schoen RE, Pinsky P, Doubeni C, Weissfeld J, Bresalier RS, Church T, Prorok P. The effect of screening on racial disparity in colorectal cancer incidence and mortaility. Gastroenterology, Digestive Diseases Week, 2013. e-Pub 2013.
25. Joe AK, Schnoll-Sussman F, Bresalier RS, Abrams JA, Hanina Hibshoosh H, Cheung K, Friedman RA, Yang C, Milne G, Liu DD, Bigg AM, Foreman J, Lee S, Tao S, Ahmes SA, Nuugat A, Lightdale CJ. Phase 1b randomized double blinded, placebo-controlled dose escalation study of polyphenon E in patients with Barrett's esophagus. Twellfth Annual International Conference on Frontiers in Cancer Prevention, 2013. e-Pub 2013.
26. Illmer M, Mazurek N, Hafley M, Vykoukal J, Alt E, Byrd JC, Bresalier RS. A TRAIL-resistant subset of cancer initiating stem cells characterized by surface galectin-3. Gastroenterology Digestive Diseases Week, 2013. e-Pub 2013.
27. Thosani N, Patel P, Raiyani TV, Raju GS, Bresalier RS, Guha S. Seeing behind the folds - Clinical impact of third eye retroscope on adenoma detection during the colonoscopy: A systematic review and Meta-Analysis. Gastroenterology, 2012. e-Pub 2012.
28. Mazurek N, Byrd JC, Bresalier RS. Cell Surface Expessionof the Anti-Apoptotic B-Galactoside-Binding Protein Galectin-3 is Characteristic of the Stem Cell Phenotype in Colorectal Cancer Cells. Gastroenterology, 2012. e-Pub 2012.
29. Schoen RE, Pinsky P, Weissfeld J, Yokochi LA, Church TR, Laiyemo AO, Bresalier RS, Riley TL, Prorok PC, Berg C. Effect of flexible sigmoidoscopy screening on incidence and mortality from colorectal cancer in the PLCO screening trial. Gastroenterology, 2012. e-Pub 2012.
30. Nguyen D, Tuck M, Sen A, Ruffin MT, Baron JA, Bresalier RS, Marcon NE, McConnell D, Stoffel EM, Syngal S, Brenner DE, Turgeon DK. Sensitivity and specificity of fecal immunochemical and guaiac testing for occult blood in archived frozen stool samples. Gastroenterology, 2012. e-Pub 2012.
31. Bresalier RS, Byrd JC, Mazurek N, Brenner D, Syngal S, Marcon N, Turgeon K, Baron JA. A Circulating Ligand for Galectin-3 Elevated in the Serum of Individuals with Colorectal Neoplasia: Results of a New ELISA Using the EDRN Reference Set. Gastroenterology, 2011. e-Pub 2011.
32. Mazurek N, Ueno S, Sun YJ, Byrd JC, Bresalier RS. Galectin-3 sequence polymorphisms predict response of colon cancer cells to chemotherapy. Gastroenterology, 2010. e-Pub 2010.
33. Song S, Ji B, Ramachandran V, Mazurek N, Wang H, Logsdon CD, Bresalier RS. Galectin-3 Induces Cell Proliferation and Invasion by Binding K-RAS and Activating RAS Signaling in Pancreatic Cancer Cells, 2010. e-Pub 2010.
34. Ueno S, San YJ, Song S, Mazurek N, Byrd JC, Irimura T, Bresalier RS. Galectin-3 polymorphisms and response of human breast and colon cancer cells to apoptotic stimuli. American Association for Cancer Research-Japanese Cancer Association Joint Conference, 2010. e-Pub 2010.
35. Song S, Bresalier RS. Galectin-3 Induces Human Pancreatic Stellate Cell Activation and IL-8 Production via NF-kB signaling. Gastroenterology, 2010. e-Pub 2010.
36. Mazurek N, Byrd JC, Sun YJ, Bresalier R. Cell-surface galectin-3 confers resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by impeding trafficking of DR4 death receptors in colon cancer cells. Gastroenterology, 2010. e-Pub 2010.
37. Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier RS, et al. Factors Associated with Inadequate Colorectal Cancer Screening with Flexible Sigmoidoscopy. Gastroenterology, 2010. e-Pub 2010.
38. Song S, Mazurek N, Liu C, Sun Y, Ding Q, Liu K, Hung MC, Bresalier R. Galectin-3 mediates nuclear B-Catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3B activity. Cancer Research 69(4):4153, 2009. e-Pub 2009.
39. Mazurek N, Byrd J, Bresalier R. Nuclear galectin-3 confers tumor necrosis factor-related apoptosis-inducing ligan (TRAIL) resistance to colon cancer cells by inhibiting caspase-8 activation. Gastroenterology, 2009. e-Pub 2009.
40. Waye J, heigh R, Fleischer S, Leighton J, Gurudu S, Aldrich L, j L, Ramrakiani S, Jonnalagadda S, Bresalier R, Kessler W, Rex D. The third eye retroscope auxillary endoscopy system improves detection of adenomas in the colon: A prospective efficacy study. Gastroenterology, 2009. e-Pub 2009.
41. Bresalier R, Byrd J, Mazurek N, Normoelle D, Brenner D, Syngal S, Marcon N, Turgeon D, Baron J. A circulating ligand for galectin-3 elevated in the serum of individuals with colorectal neoplasia:Results of a new ELISA using the EDRN reference set. Procedings of the 6th EDRN Scientific Workshop, 2009. e-Pub 2009.
42. Laiyemo A, Doubeni C, Pinsky P, Doria-Rose P, Bresalier R. Race, ethnicity and colorectal disparities: Is there a difference in adenoma indication? Evidence from 16 prostate, lung, colorectal and ovarian (PLCO) cancer screening trials. Gastroenterology, 2009. e-Pub 2009.
43. Schoen R, j W, Laiyamo A, Doria-Rose P, Bresalier R, Clark T, l Y, O'Brien, B, Pinsky P. Comparison of 16 years of flexible sigmoidoscopy (FSG) at three versus five years after a negative exam. Gastroenterology, 2009. e-Pub 2009.
44. Mazurek N, Byrd J, Sun Y, Bresalier R. Galectin-3 sequence polymorphisms dictate TRAIL sensativity or resistance of human breast cancer cells. Proceedings of the American Association of Cancer Research 50:27, 2009. e-Pub 2009.
45. Waye J, Heigh R, Fleicher D, Leighton J, Aldrich, Li J, Ramrakhiani S, Edmundowicz S, Early D, Bresalier RS, Kessler W, Rex D. A prospective efficacy study of the Third Eye Retroscope Auxiliary Endoscope System. Gastroenterology, 2008. e-Pub 2008.
46. Song S, Mori-Akayama Y, Liu K, de Crombrugghe B, Bresalier RS. Regulation of SOX-9 and Wnt signaling in human colon cancer cells. Gastroenterology 134:A76, 2008. e-Pub 2008.
47. Byrd J, Yan P, Bresalier R. Expression of MAC-2 BP, ligand for galectin-3, in Barrett's esophagus, esophageal adenocarcinoma and squamous cell carcinoma. Proceedings of the XXVII Congress of the International Academy of Pathology, 2008. e-Pub 2008.
48. Song S, Mazurek N, Liu C, Liu KF, Bresalier RS. Galectin-3 mediates nuclear Beta-catenin accumulation and Wnt signaling in human colon cancer cells through regulation of Gsk-3beta activity. Gastroenterology 132:A129, 2007. e-Pub 2007.
49. Half E, Song S, Sun Y, Bresalier RS. Sulindac and Gefitinib inhibit MUC2 and MUC5AC mucin expression via Akt and Mapk pathways in human colon cancer cells. Gastroenterology 132:A306, 2007. e-Pub 2007.
50. Song S, Byrd J, Bresalier RS. Differential regulation of COX-2 and cyclin D1 by bile acids at neutral and acid pH in esophageal adenocarcinoma cells. Gastroenterology 132:A417, 2007. e-Pub 2007.
51. Bresalier, RS. Galection targets: the role of galectin-3 in the progression and metastasis of colorectal neoplasia. Proceedings of the American Chemical Society, 2007. e-Pub 2007.
52. Bresalier RS, Sun YJ, Liu KF, Mazurek N. Impaired galectin-3 phosphorylation leads to PTEN loss and acquision of TRAIL-resistance in human breast cancer cells. Proc Am Assoc Cancer Res 47:A177, 2006. e-Pub 2006.
53. Stoffel E, Stockwell DH, Normole D, Tuck M, Narcon N Turgeon DK, Baron J, Arber N, Bresalier RS, Syngal S, Brenner D. Chromoendoscopic colonoscopy detects more adenomas than conventional colonoscopy: a randomized trial of back-to-back colonoscopies. Gastroenterology 130:A48, 2006. e-Pub 2006.
54. Half E, Broaddus RR, Liu KF, Mansfield P, Bresalier RS. EGFR proteins are highly expressed in Pseudomyxoma peritonei. Gastroenterology 130:A276, 2006. e-Pub 2006.
55. Chakraborty A, Tong Z, Liu KF, Bresalier RS, Gha S. Granulocyte colony stimulating factor receptor promotes beta 1-integrin mediated adhesion and invasion of pancreatic cancer cells. Gastroenterology 130:A278, 2006. e-Pub 2006.
56. Anandasabapathy S, Davila M, Wei C, Morris J, Bresalier RS. Clinical and endoscopic factors predict higher pathologic grades of Barrett's esophagus. Gastroenterology 130:A412, 2006. e-Pub 2006.
57. Mazurek N, Sun Y, Liu K, Bresalier. Galectin-3 loss leads to PTEN down-regulation and acquisition of TRAIL-resistance in human colon cancer cells. Gasroenterology 130:A97, 2006. e-Pub 2006.
58. Liu KF, Byrd JC, Song S, Bresalier RS. Expression of galectin-3 and its binding protein (Mac-2BP) correlates with tumor progression and metastasis of colorectal adenocarcinoma. Gastroenterology 130:A88, 2006. e-Pub 2006.
59. Song S, Krishnan K, Liu KF, Bresalier RS. Polyphenon E inhibits growth of malignant human esophageal epithelial cells by downregulation of CREB and cyclin D1. Gastroenterology 130:A102, 2006. e-Pub 2006.
60. Bresalier RS. Induction of COX-2 by unconjugated bile acids involves AP-1, CREB and reactive oxygen species-mediated signaling pathways in esophageal adenocarcinoma cells. Gastroenterology 130:A128, 2006. e-Pub 2006.
61. Cole B, Baron J, Sandler R, Haile R, Ahnen D, Bresalier RS, McKeown-Eyssen G, Summers R, Rothstein R, Burke C, Snover D, Church T, Byers T. A randomized trial of folic acid to prevent colorectal adenomas. Proc Am Assoc Cancer Res, 2005. e-Pub 2005.
62. Mazurek N, Sun Y, Evans R, Nangia-Makker P, Raz A, Bresalier RS. Phosphorylation of galectin-3 is required for sensitizing human epithelial cells to TRAIL induced apoptosis via induction of pTEN. Proc Am Assoc Cancer Res, 2005. e-Pub 2005.
63. Hong BS, Lunagomez S, Kim E, Morris J, Swisher SG, Bresalier RS, Ajani J. The number of abnormalities on pre-treatment PET scan predicts for overall survival of patients with localized esophageal and GE junction carcinoma. Proc Am Soc Thoracic Surg, 2005. e-Pub 2005.
64. Schoen RE, Weissfeld JL, Pinsky P, Bresalier RS, Austin J, Prostate Lung RTFT, Colorectal, Screening Trial OC. Diagnostic yield based on polyp size detected at screening flexible sigmoidoscopy (FSG): implications for virtual colonoscopy. Gastroenterology, 2005. e-Pub 2005.
65. Lanas A, Bresalier RS, Sandler R, Bolognese J, Qan H, Oxenius B, Horgan K, Riddell R, Morton D, Baron JA. Upper gastrointestinal events associated with rofecoxib in a colorectal adenoma chemoprevention trial. Gastroenterology 129:371, 2005. e-Pub 2005.
66. Phan A, Rashid A, Luthra R, Lopez-Alvarez E, Swisher S, Komaki R, Bresalier R, Ajani A. Oncogene/tumor suppressor gene expression impacts overall survival of patients with localized upper gastrointestinal cancers. Proc Am Soc Clin Oncol, 2005. e-Pub 2005.
67. Malaisre SC, Swisher SG, Correa AM, Ajani J, Komaki DC, Vaporciyan AA, Walsj G, Lahoti S, Bresalier R, Roth J. Celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiation in patients with adenocarcinoma of the distal esophagus. Proc Soc of Thoracic Surgeons, 2005. e-Pub 2005.
68. Bresalier RS, Sandler RS, Bolognese J, Quan H, Oxenius B, Joseph R, Horgan K, Riddell R, Morton D, Lanas A, Baron J. A randomized trial of rofecoxib to prevent colorectal adenomas: the APPROVe Trial. Gastroenterology, 2005. e-Pub 2005.
69. Schoen RE, Weissfeld JL, Pinsky P, Bresalier RS, Austin J, Riley T. The Prostate Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Diagnostic yield based on polyp size detected at screening flexible sigmoidoscopy (FSG):implications for virtual colonoscopy. Gastroenterology, 2005. e-Pub 2005.
70. Liu KF, Byrd JC, Half E, Broaddus R, Finegold M, Bresalier RS. Expression of mucin antigens in pseudomyxoma peritonei as compared to mucinous colon cancer. Gastroenterology, 2005. e-Pub 2005.
71. Byrd JC, Liu KF, Izzo J, Wu TT, Song S, Bresalier RS. Galectin-3 and MUC2 intestinal mucin in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology, 2005. e-Pub 2005.
72. Song S, Byrd JC, Liu KF, Ko J, Koul D, Bresalier RS. Induction of MUC5AC and COX-2 by conjugated and unconjugated bile acids in Barrett's adenocarcinoma cells. Gastroenterology, 2005. e-Pub 2005.
73. Izzo JG, Wu TT, Luthra R, Malhotra U, Luthra M, Milas L, Liao Z, Swisher S, Lee JH, Bresalier RS, Hittelman WN, Aggarwal BB, Ajani JA. Activated Transcription Factor NF-kB is Associated with Chemo-Radiotherapy Resistance and Poor Outcome in Esophageal Adenocarcinoma. Proc Am Assoc Cancer Res,, 2005. e-Pub 2005.
74. Mazurek N, Byrd JC, Ramdas L, Raz A, Bresalier RS. Phosphorylation of galectin-3 modulates gene expression. Proc Am Assoc Cancer Res,, 2004. e-Pub 2004.
75. Half E, Sun Y, Mazurek N, Byrd JC, Bresalier RS. Gefitinib and sulindac have an additive effect on inhibition of Uc2 and MUC5A mucin expresin in human colon cancer cells. Gastroenterology 16:A-503, 2004. e-Pub 2004.
76. Bresalier, Robert S. Bile acids induce MUC2 over-expression in human colon cancer cells. Gastroenterology 126:A114-115, 2004. e-Pub 2004.
77. Song S, Byrd JC, Koo JP, K-F L, Bresalier RS. Galectin-3 modulates MUC2 expression in human colon cancer cells at the level of transcription through AP-1 activation. Gastroenterology 126:A-101, 2004. e-Pub 2004.
78. Bresalier RS, Sandler R, Riddell R, Lanas A, Morton D, Reicin A, Oxenious B, Horgan K, Quan H, Baron J. VIOXX (rofecoxib) APPROVe study Preliminary Report on Cardiovascular Safety,. American College of Rheumatology, 2004. e-Pub 2004.
79. Bresalier RS, Holt P. Neoplasia-associated expression of MUC5AC mucin is reduced in adenomas by treatment with calcium and vitamin D. Gastroenterology 122:A71, 2002. e-Pub 2002.
80. Mazurek N, Byrd JC, Tessler D, Lebel J, Yunker C, Bresalier RS. Identification of a colon cancer-associated 40-kilodalton ligand for galectin-3 serum as a haptoglobin-related glycoprotein. Gastroenterology 122:A480, 2002. e-Pub 2002.
81. Schoen RE, Weissfeld JL, Bresalier RS, Church T, Yokochi L, Pinsky P, Prorok P. The yield of flexible sigmoidoscopy (FS) three years after a negative exam: Results from the PLCO trial. Gastroenterology 122:A40, 2002. e-Pub 2002.
82. Bresalier RS, Pinsky P, Weissfeld J, Schoen R, Church T, Yokochi L, Prorok P. Effectiveness of nurse endoscopists in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Gastroenterology 122:A479, 2002. e-Pub 2002.
83. Baron J, Cole BF, Mott LA, et al. Aspirin chemoprevention of colorectal adenomas. Proc Am Assoc Cancer Res, 2002. e-Pub 2002.
84. Nangia-Makker P, Hogan V, Honjo, Baccarini S, Tait L, Bresalier RS, Raz A. A simple sugar-modified citrus pectin acts as a potential anti-metastatic non-toxic therapeutic agent. Clin and Exp Metastasis 19 (suppl 1):13, 2002. e-Pub 2002.
85. Huang WY, Kang D, Weissfeld JL, Bresalier RS, Hayes RB. DNA repair polymorphisms and risk of colorectal adenoma in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Society for Epidemiologic Research. Proceedings. American Journal of Epidemiology 155 (11):047, 2002. e-Pub 2002.
86. Peters U, Hayes R, Schatzkin A, Weisfeld J, Bresalier RS. New life for the dietary fiber and colorectal neoplasia hypothesis? Data from the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) trial. Proceedings of the Congress of Epidemiology, 2002. e-Pub 2002.
87. Peters U, Chatterjee N, Hayes RB, Schoen R, Church T, Bresalier RS, Gaudet M, Flood A, Schatzkin A, McGlynn K. Association of calcium intake and colorectal adenoma. Society for Epidemiologic Research. Proceedings American Journal of Epidemiology 155(11):047, 2002. e-Pub 2002.
88. Mazurek N, Conklin J, Raz A, Bresalier RS. Phosphorylation modulates the binding of the B-galactoside binding protein galectin-3 to laminin and colon cancer mucin. Proc Am Assoc Cancer 41:164, 2000. e-Pub 2000.
89. Sternberg LR, Yunker CK, Bresalier RS. The human MUC2 gene encodes multiple mRNA transcripts. Gastroenterology: Presentation of Distinction 118:A283, 2000. e-Pub 2000.
90. Dudas S, Yunker CK, Sternberg LR, Bresalier RS. Expression of human intestinal mucin (MUC2) is modulated by the B-galactoside binding protein galectin-3 in human colon cancer cells. Gastroenterology: Presentation of Distinction 118:A273, 2000. e-Pub 2000.
91. Weissfeld J, Ling B, Schoen R, Bresalier RS, Riley T. Repeat screening flexible sigmoidoscopy in the Prostate, Lung Colorectal and Ovarian (PLCO) Cancer Screening Trial. Gastroenterology 118:A441, 2000. e-Pub 2000.
92. Ahnen D, Hines S, Vanoni C, Colange N, Flynn P, Bresalier RS. Promoting colon cancer screening among first degree relatives of colon cancer patients. Gastroenterology 118:A2428, 2000. e-Pub 2000.

Book Chapters

1. Bresalier RS. Colorectal Cancer. In: Gastrointestinal Disease. 10th Edition. WB Saunders, 2248-2296, 2016.
2. Bresalier RS. Colonic polyps and polyposis syndromes. In: Surgery Scientific Principls and Practices. Sixth. Lipncott, 2016.
3. Bresalier RS. Tumors of the small intestine. In: Gastrointestinal Disease. 10th Edition. WB Saunders, 2196-2212, 2016.
4. Byrd JC, Mazurek N, Bresalier RS. Post translational modification of galectin-3 and its role in biological function. In: Klyosov AA and Traber PG Galectins and Disease. Implications for targeted therapeutics. John Wiley and Sons, 158-175, 2012.
5. Boland C, Bresalier R. Colonic polyps and polyposis syndromes. In: Surgery Scientific Principles and Practices. Fifth. Lippncott, 2011.
6. Bresalier R. Malignant Neoplasms of the Large Intestine. In: Gastrointestinal Disease. Ninth. WB Saunders, 2155-2190, 2010.
7. Davila M, Bresalier R. Gastrointestinal complications of cancer treatment. In: Holland-Frei Cancer Medicine. eighth. Hamilton, 2010.
8. Bresalier RS. Tumors of the Small Intestine. In: Atlas of Gastroenterology. 4th edition. Lippincott, 1322-1342, 2009.
9. Bresalier RS, Anandasabapathy S. Tumors of the Small Intestine. In: Textbook of Gastroenterology. 5th edition, 358-373, 2009.
10. Byrd JC, Bresalier RS. Galectin-3 in the progression and metastasis of colorectal neoplasia. In: Galectins. John Wiley and Sons, 221-232, 2009.
11. Bresalier RS. Epidemiology, Genetics and Prevention of Colorectal Cancer. In: Atlas of Cancer Second Edition. Upper and Lower GI Tract Cancers. Second Edition, 2008.
12. Bresalier RS. Malignant Neoplasms of the Large Intestine. In: Gastrointestinal Disease. Eighth Edition. WB Saunders, 2759-2810, 2006.
13. Bresalier RS, Boland CR. Colonic Polyps and Polyposis Syndromes. In: Surgery Scientific Principles and Practices 4th Edition. 4th Edition, 1080-1102, 2005.
14. Davila M, Bresalier RS. Gastrointestinal Complications. In: Holland-Frei. Cancer Medicine. 7th Edition, 2005.
15. Bresalier RS. Colorectal Cancer. In: Gastrointestinal and Liver Tumors. Springer, 99-116, 2004.
16. Bresalier RS. Colorectal Neoplasia. In: Requisites for Gastroenterology. Small and Large Intestine. Harcourt Health Science, 159-194, 2004.
17. Bresalier RS. Malignant Neoplasms of the Small Intestine. In: Textbook of Gastroenterology. Lippincott, 1643-1662, 2003.
18. Bresalier, RS. Tumors of the Small Intestine. In: Atlas of Gastroenterology. Lippincott, 362-378, 2003.
19. Bresalier RS. Stress-related Gastrointestinal Hemorrhage. In: Acute Gastrointestinal Bleeding: Diagnosis and Treatment. Humana Press, 57-74, 2003.
20. Bresalier RS. Malignant and Premalignant Lesions of the Colon. In: Current Diagnosis and Treatment in Gastroenterology, Second Edition. Second Edition. Lange, 407-435, 2003.
21. Bresalier RS. Pharmacologic prevention of colorectal cancer. In: Exogenous Factors in Colonic Carcinogenesis. Kluwer, 306, 2003.
22. Bresalier RS. Malignant Neoplasms of the Large Intestine. In: Gastrointestinal Disease, Seventh Edition. Seventh Edition. WB Saunders, 2215-2261, 2003.
23. Bresalier RS, Boland CR. Colonic Polyps and Polyposis Syndromes. In: Surgery Scientific Principles and Practices 3rd Edition. Lippincott, 1089-1109, 2001.
24. Nangia-Makker P, Akahana S. The role of galectin-3 in tumor metastasis. In: Lectins and Pathology. Hardwood Academic Publishers, 67-77, 2000.
25. Bresalier RS, Kim YS. Malignant neoplasms of the colon. In: Gastrointestinal Disease, Sixth Edition. Sixth Edition. WB Saunders, 1906-1942, 1998.
26. Boland CR, Bresalier RS. Colonic polyps and polyosis syndromes. In: Surgery: Scientific Principles and Practices. JB Lippincott, 1128-1145, 1997.
27. Boland CR, Bresalier RS. Colonic polyps and polyposis syndromes. In: Essentials of Surgery. Lippincott Raven, 339-344, 1997.
28. Bresalier, RS. Neoclassic of the Colon and Rectum. In: Slide Atlas of Gastroenterology and Hepatology. Current Medicine, 1996.
29. Bresalier, R S. Neoplasia of the Colon and Rectum. In: Gastroenterology and Hepatology. The Comprehensive Visual Reference. Current Medicine, 3.1-3.28, 1996.
30. Bresalier, R S. Gastrointestinal Neoplasms. In: Clinical Manual on Geriatrics. Appleton and Lange, 308-331, 1996.
31. Bresalier RS. Malignant and premalignant lesions of the colon. In: Current Diagnosis and Treatment in Gastroenterology. Appleton and Lange, 367-391, 1995.
32. Bresalier RS. Sucralfate for prevention of acute gastrointestinal bleeding. In: Sucralfate in the Nineties. Plenum Publ, 289-301, 1995.
33. Bresalier RS. Colonic neoplasms. In: Principles and Practices of Gastroenterology and Hepatology, 2nd edition. 2nd. Elsevier Science Publishers, 343-368, 1994.
34. Bresalier RS, Kim YS. Malignant neoplasms of the colon. In: Gastrointestinal Disease. WB Saunders and Co, 149-1493, 1993.
35. Bresalier RS, Toribara NW. Familial Colon Cancer. In: Premalignant Conditions of the Gastrointestinal Tract. Controversies in Gastroenterology Series. Elsevier Science Publishers, 227-244, 1991.
36. Bresalier RS, Kim YS. Characterization of colon carcinoma cell metastases in model systems. In: Colon Carcinoma Cells. Cell Biology Monograph Series. Academic Press Inc,, 341-368, 1990.
37. Toribara NW, Ho SB, Bresalier RS, Kim YS. Biochemical changes in colorectal carcinogenesis. In: Colorectal Carcinogenesis. An Approach to Cancer Prevention. Springer Verlag, 256-288, 1989.
38. Bresalier RS, Itzkowitz SH, Kim YS. Current concepts of colon cancer. In: Principles and Practices of Gastroenterology and Hepatology. Elsevier Science Publishers, 497-523, 1988.
39. Bresalier RS, Kim YS. Malignant neoplasms of the large and small intestine. In: Gastrointestinal Disease, Fourth Edition. Fourth edition. WB Saunders & Co, 1519-1560, 1988.
40. Ho SB, Toribara NW, Bresalier RS, Kim YS. Biochemical and other markers of colon cancer. In: Colorectal Cancer. Gastroenterol Clin North Am, Vol 17, No 4. Saunders WB, 811-836, 1988.
41. Bresalier RS, Boland CR, Sack T, Kim YS. Cancer of the gastrointestinal tract. In: The Gastrointestinal Annual 3. Elsevier Science Publishers, 413-469, 1986.
42. Kam WK, Bresalier RS, Kim YS. The expression of alkaline phosphatases in human gastrointestinal and pancreatic tissues and cell lines. In: Progress in Clinical and Biologic Research. Alan R Liss, Publishers, 207-222, 1984.
43. Bresalier RS, Boland CR, Itzkowitz SH, Kim YS. Basic Gastrointestinal Oncology. In: Gastrointestinal Annual 2. Elsevier Science Publishers, 272-319, 1984.
44. Bresalier RS. Tumors of the small intestine. In: Gastrointestinal Disease. 11th Edition. WB Saunders.
45. Bresalier RS, Blechacz B. Gastrointestinal complications of cancer treatment. In: Holland-Frei Cancer Medicine. Ninth. Kufe D, Bast R, Hait W, Hong W, Pollack R, Weichselbaum R, Holland J, Frei E.
46. Bresalier RS. Colorectal Cancer. In: Gastrointestinal Disease. 11th Edition. WB Saunders.

Books (edited and written)

1. Bresalier RS, Souza R. Barrett’s Esophagus: What Do We Really Know: a Goblet (Cell) Half Full. Digestive Diseases and Sciences special edition, 2018.
2. Ahnen D, Bresalier RS. Screening for Colorectal Cancer. Ed(s) Special Edition, 2015.
3. Bresalier R, Bhutani M, Eds. Atlas of Gastrointestinal Cancer: A Multidisciplinary Approach to Diagnosis, Staging and Treatment. John Wiley & Sons Ltd, 2011.
4. Bresalier RS, Editor S. Disorders of the Gastrointestinal Tract and Nutrition. BC Decker, 2009.
5. Bresalier RS. Current Opinion in Gastroenterology. Lippincott, Williams and Wilkins, 2009.
6. Bresalier, RS. Current Opinion in Gastroenterology. Lippincott, Williams and Wilkins, 2008.
7. Bresalier, RS. Current Opinion in Gastroenterology. Lippincott, Williams and Wilkins, 2007.
8. Bresalier, RS. Current Treatment Options in Gastroenterology. Current Science, 2007.
9. Bresalier RS, Arber N. Current Science, 2006.
10. Bresalier RS. Large Intestine. Lippincott, Williams and Wilkins, 2006.
11. Bresalier RS. Current Treatment Options in Gastroenterology. Current Science, 2006.
12. Bresalier RS. Current Treatment Options in Gastroenterology. Current Science, 2005.
13. Bresalier, Robert S. Current Opinion in Gastroenterology. Ed(s) Vol 21, No. 1. Lippincott, Williams and Wilkins, 2005.
14. Bresalier, Robert S. Current Treatment Options in Gastroenterolgy. Current Science, 2004.
15. Bresalier, Robert S. Current Opinion in Gastroenterology. Ed(s) Vol 20 No 1. Lippincott, Williams and Wilkins, 2004.
16. Bresalier, Robert S. Colorectal Cancer. Kluwer/Plenum, 2004.
17. Scheppach W, Bresalier RS. Gastrointestinal and Liver Tumors. Springer, 2003.
18. Bresalier RS. Current Treatment Options in Gastroenterology, Colon and Anorectum. Current Science, 2003.
19. Bresalier RS. Current Opinion in Gastroenterology. Ed(s) Vol. 19 No 1. Lippincott, Williams and Wilkins, 2003.
20. Bresalier RS. Current Opinion in Gastroenterology. Ed(s) Vol 18, No. 1. Lippincott, Williams and Wilkins, 2002.
21. Bresalier RS. Current Treatment Options in Gastroenterology. Ed(s) Vol 5, No 3. Current Science, 2002.
22. Bresalier RS. Current Treatment Options in Gastroenterology. Ed(s) Vol 4, No. 3. Current Science, 2001.
23. Bresalier RS. Current Opinion in Gastroenterology. Ed(s) Vol 17, No 1. Lippincott, Williams and Wilkins, 2001.
24. Bresalier RS. Current Treatment Options in Gastroenterology. Ed(s) Vol 3, No 3. Current Science, 2000.
25. Bresalier RS. Current Opinion in Gastroenterology. Ed(s) Vol 16, No. 1. Lippincott, Williams and Wilkins, 2000.
26. Bresalier RS. Current Treatment Options in Gastroenterology. Ed(s) Vol 2, No. 6. Current Science, 1999.

Letters to the Editor

1. Zuo, X, Wang, L, Liu, Y, Wang, H, Hafley, M, Gagea Iurascu, M, Chen, R, Xiong, Y, Pan, S, Shureiqi, I, Bresalier, R, Wei, D. Dysregulated KLF4 expression plays a pivotal role in the pathogenesis of pancreatic intraductal papillary mucinous neoplasms. Gut 74: 327-329, 2025.
2. Bresalier RS, Baron JA. Adverse cardiovascular effects of rofecoxib (correspondence). N Engl J Med 355: 203-205, 2006.

Patents

1. Biomarker for Detecting Cancer. Patent Number: 14.359,824.
2. COX-2 inhibitions in chemoprevention of colorectal neoplasia. Patent Number: N/A.
3. Biomarker for Detecting Cancer. Patent Number: UTSC.P10497S.C1.